Login Register Cart 0
Generic placeholder image

Combinatorial Chemistry & High Throughput Screening

Editor-in-Chief

ISSN (Print): 1386-2073
ISSN (Online): 1875-5402

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Chiral Inversion of Pharmaceutical Drugs - Mini Review

Author(s): Hassan Y. Aboul-Enein*, Valliappan Kannappan and Selvakumar Kanthiah

Volume 26, Issue 15, 2023

Published on: 14 February, 2023

Page: [2577 - 2582] Pages: 6

DOI: 10.2174/1386207326666230102123655

Price: $65

conference banner
Abstract

2-Arylpropionic acid nonsteroidal anti-inflammatory drugs (NSAIDs) provide one of the most demonstrated pharmaceutical examples of chiral inversion. Chiral inversion depends on various factors (viz. biological-, solvent-, light-, temperature-induced, etc.) and the energy barrier associated with the stereogenic element present in the chiral molecule. The pharmacological properties of chiral drugs depend on the activity of one enantiomer or both the enantiomers targeting different biological targets. Consequently, chiral inversion can alter the biological activities of the pharmaceutical drug. Hence a better understanding of chiral inversion, factors facilitating such inversion, and the tools employed to determine chiral inversion are of great significance from a pharmacological and toxicological perspective.

« Previous Next »
Graphical Abstract

[1]
Nkomo, S.; Sanganyado, E. Chiral inversion of organic pollutants in chiral organic pollutants: Monitoring and characterization in food and the environment; CRC Press: Boca Raton, FL, USA, 2020, pp. 27-40.
[http://dx.doi.org/10.1201/9781003000167-3]
[2]
Eriksson, T.; Björkman, S.; Höglund, P. Clinical pharmacology of thalidomide. Eur. J. Clin. Pharmacol., 2001, 57(5), 365-376.
[http://dx.doi.org/10.1007/s002280100320] [PMID: 11599654]
[3]
Nguyen, L.A.; He, H.; Pham-Huy, C. Chiral drugs: An overview. Int. J. Biomed. Sci., 2006, 2(2), 85-100.
[PMID: 23674971]
[4]
Caldwell, J.; Hutt, A.J.; Fournel-Gigleux, S. The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. Biochem. Pharmacol., 1988, 37(1), 105-114.
[http://dx.doi.org/10.1016/0006-2952(88)90762-9] [PMID: 3276314]
[5]
Siódmiak, J.; Siódmiak, T.; Tarczykowska, A.; Czirson, K.; Dulęba, J.; Marszałł, M.P. Metabolic chiral inversion of 2-arylpropionic acid derivatives (profens). Med. Res. J., 2017, 2(1), 1-5.
[http://dx.doi.org/10.5603/MRJ.2017.0001]
[6]
Wsól, V.; Skálová, L.; Szotáková, B. Chiral inversion of drugs: Coincidence or principle? Curr. Drug Metab., 2004, 5(6), 517-533.
[http://dx.doi.org/10.2174/1389200043335360] [PMID: 15578945]
[7]
Wang, Y.X.; Gong, N.; Xin, Y.F.; Hao, B.; Zhou, X.J.; Pang, C.C.Y. Biological implications of oxidation and unidirectional chiral inversion of D-amino acids. Curr. Drug Metab., 2012, 13(3), 321-331.
[http://dx.doi.org/10.2174/138920012799320392] [PMID: 22304623]
[8]
Lehmann, W.D.; Theobald, N.; Fischer, R.; Heinrich, H.C. Stereospecificity of phenylalanine plasma kinetics and hydroxylation in man following oral application of a stable isotope-labelled pseudo-racemic mixture of l- and d-phenylalanine. Clin. Chim. Acta, 1983, 128(2-3), 181-198.
[http://dx.doi.org/10.1016/0009-8981(83)90319-4] [PMID: 6851137]
[9]
Nguyen, A.Q.; Nguyen, L.N.; McDonald, J.A.; Nghiem, L.D.; Leusch, F.D.L.; Neale, P.A.; Khan, S.J. Chiral inversion of 2-arylpropionoic acid (2-APA) enantiomers during simulated biological wastewater treatment. Water Res., 2022, 209, 117871.
[http://dx.doi.org/10.1016/j.watres.2021.117871] [PMID: 34872028]
[10]
Aso, Y.; Yoshioka, S.; Takeda, Y. Epimerization and racemization of some chiral drugs in the presence of human serum albumin. Chem. Pharm. Bull., 1990, 38(1), 180-184.
[http://dx.doi.org/10.1248/cpb.38.180] [PMID: 2337941]
[11]
Jamali, F.; Mehvar, R.; Pasutto, F.M. Enantioselective aspects of drug action and disposition: Therapeutic pitfalls. J. Pharm. Sci., 1989, 78(9), 695-715.
[http://dx.doi.org/10.1002/jps.2600780902] [PMID: 2685226]
[12]
Vakily, M.; Corrigan, B.; Jamali, F. The problem of racemization in the stereospecific assay and pharmacokinetic evaluation of ketorolac in human and rats. Pharm. Res., 1995, 12(11), 1652-1657.
[http://dx.doi.org/10.1023/A:1016245101389] [PMID: 8592665]
[13]
Edwards, S.R.; Mather, L.E. Tissue uptake of ketamine and norketamine enantiomers in the rat Indirect evidence for extrahepatic metabolic inversion. Life Sci., 2001, 69(17), 2051-2066.
[http://dx.doi.org/10.1016/S0024-3205(01)01287-5] [PMID: 11589520]
[14]
Fernandez, C.; Alet, P.; Davrinche, C.; Adrien, J.; Thuillier, A.; Farinotti, R.; Gimenez, F. Stereoselective distribution and stereoconversion of zopiclone enantiomers in plasma and brain tissues in rats. J. Pharm. Pharmacol., 2010, 54(3), 335-340.
[http://dx.doi.org/10.1211/0022357021778574] [PMID: 11902799]
[15]
Reist, M.; Roy-de, V.M.; Montseny, J.P.; Mayer, J.M.; Carrupt, P.A.; Berger, Y.; Testa, B. Very slow chiral inversion of clopidogrel in rats: A pharmacokinetic and mechanistic investigation. Drug Metab. Dispos., 2000, 28(12), 1405-1410.
[PMID: 11095576]
[16]
Virkel, G.; Lifschitz, A.; Pis, A.; Lanusse, C. In vitro ruminal biotransformation of benzimidazole sulphoxide anthelmintics: Enantioselective sulphoreduction in sheep and cattle. J. Vet. Pharmacol. Ther., 2002, 25, 15-23.
[http://dx.doi.org/10.1046/j.1365-2885.2002.00373.x]
[17]
Walters, R.R.; Hsu, C.Y.L. Chiral assay methods for lifibrol and metabolites in plasma and the observation of unidirectional chiral inversion following administration of the enantiomers to dogs. Chirality, 1994, 6(2), 105-115.
[http://dx.doi.org/10.1002/chir.530060211] [PMID: 8204414]
[18]
Welch, C.J.; Kress, M.H.; Beconi, M.; Mathre, D.J. Studies on the racemization of a stereolabile 5-aryl-thiazolidinedione. Chirality, 2003, 15(2), 143-147.
[http://dx.doi.org/10.1002/chir.10180] [PMID: 12520506]
[19]
Masubuchi, N.; Yamazaki, H.; Tanaka, M. Stereoselective chiral inversion of pantoprazole enantiomers after separate doses to rats. Chirality, 1998, 10(8), 747-753.
[http://dx.doi.org/10.1002/(SICI)1520-636X(1998)10:8<747:AID-CHIR5>3.0.CO;2-B] [PMID: 9803530]
[20]
Easson, L.H.; Stedman, E. Studies on the relationship between chemical constitution and physiological action. Biochem. J., 1933, 27(4), 1257-1266.
[http://dx.doi.org/10.1042/bj0271257] [PMID: 16745220]
[21]
Cadlwell, J. Chiral pharmacology and the regulation of new drugs. Chem. Ind., 1995, 6, 176-179.
[22]
Ariëns, E.J. Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur. J. Clin. Pharmacol., 1984, 26(6), 663-668.
[http://dx.doi.org/10.1007/BF00541922] [PMID: 6092093]
[23]
Ali, I.; Gupta, V.K.; Aboul-Enein, H.Y.; Singh, P.; Sharma, B. Role of racemization in optically active drugs development. Chirality, 2007, 19(6), 453-463.
[http://dx.doi.org/10.1002/chir.20397] [PMID: 17393472]
[24]
Reichel, C.; Brugger, R.; Bang, H.; Geisslinger, G.; Brune, K. Molecular cloning and expression of a 2-arylpropionyl-coenzyme A epimerase: A key enzyme in the inversion metabolism of ibuprofen. Mol. Pharmacol., 1997, 51(4), 576-582.
[http://dx.doi.org/10.1124/mol.51.4.576] [PMID: 9106621]
[25]
Goto, J.; Goto, N.; Nambara, T. Separation and determination of naproxen enantiomers in serum by high-performance liquid chromatography. J. Chromatogr. A, 1982, 239, 559-564.
[http://dx.doi.org/10.1016/S0021-9673(00)82013-0]
[26]
Berry, B.W.; Jamali, F. Presystemic and systemic chiral inversion of R-(-)-fenoprofen in the rat. J. Pharmacol. Exp. Ther., 1991, 258(2), 695-701.
[PMID: 1865366]
[27]
Hutt, A.J.; Caldwell, J. The metabolic chiral inversion of 2-arylpropionic acids—a novel route with pharmacological consequences. J. Pharm. Pharmacol., 2011, 35(11), 693-704.
[http://dx.doi.org/10.1111/j.2042-7158.1983.tb02874.x] [PMID: 6139449]
[28]
Tynes, C.R.; Livingston, B.; Patel, H.; Arnold, J.J. Chiral stability of an extemporaneously prepared clopidogrel bisulfate oral suspension. J. Pediatr. Pharmacol. Ther., 2014, 19(1), 25-29.
[http://dx.doi.org/10.5863/1551-6776-19.1.25] [PMID: 24782688]
[29]
Matsumoto, A.; Fujiwara, S.; Hiyoshi, Y.; Zawatzky, K.; Makarov, A.A.; Welch, C.J.; Soai, K. Unusual reversal of enantioselectivity in the asymmetric autocatalysis of pyrimidyl alkanol triggered by chiral aromatic alkanols and amines. Org. Biomol. Chem., 2016, 15, 555-558.
[http://dx.doi.org/10.1039/C6OB02415G]
[30]
Zhou, Z.; Zhou, J.; Chen, L.; Zhao, Q.; Zhang, C.; Ge, G. Chirality reversal, enhancement and transfer by pH-adjusted surfactant assembly. Chem. Commun., 2020, 56(97), 15345-15348.
[http://dx.doi.org/10.1039/D0CC07008D] [PMID: 33231225]
[31]
Muller, N.; Payan, E.; Lapicque, F.; Bannwarth, B.; Netter, P. Pharmacological aspects of chiral nonsteroidal anti-inflammatory drugs. Fundam. Clin. Pharmacol., 1990, 4(6), 617-634.
[http://dx.doi.org/10.1111/j.1472-8206.1990.tb00042.x] [PMID: 2096103]
[32]
Williams, K.M.; Day, R.O. The contribution of enantiomers to variability in response to anti-inflammatory drugs. Agents Actions Suppl., 1988, 24, 76-84.
[http://dx.doi.org/10.1007/978-3-0348-9160-8_7] [PMID: 3142235]
[33]
Mu, L.L.; Cheng, Z.N.; Guo, X.; Luo, X.; Yu, P. Investigation of chiral inversion and pharmacokinetics of laevo-ornidazole by high-performance liquid chromatography. J. Clin. Pharm. Ther., 2013, 38(1), 31-35.
[http://dx.doi.org/10.1111/jcpt.12015] [PMID: 23167572]
[34]
Wolf, C. Stereolabile chiral compounds: Analysis by dynamic chromatography and stopped-flow methods. Chem. Soc. Rev., 2005, 34(7), 595-608.
[http://dx.doi.org/10.1039/b502508g] [PMID: 15965541]
[35]
Krupcik, J.; Oswald, P.; Májek, P.; Sandra, P.; Armstrong, D.W. Determination of the interconversion energy barrier of enantiomers by separation methods. J. Chromatogr. A, 2003, 1000(1-2), 779-800.
[http://dx.doi.org/10.1016/S0021-9673(03)00238-3] [PMID: 12877200]
[36]
Sanganyado, E.; Lu, Z.; Fu, Q.; Schlenk, D.; Gan, J. Chiral pharmaceuticals: A review on their environmental occurrence and fate processes. Water Res., 2017, 124, 527-542.
[http://dx.doi.org/10.1016/j.watres.2017.08.003] [PMID: 28806704]
[37]
Chen, L.; Dean, B.; La, H.; Chen, Y.; Liang, X. Stereoselective supercritical fluidic chromatography-mass spectrometry (SFC-MS) as a fast bioanalytical tool to assess chiral inversion in vivo and in vitro. Int. J. Mass Spectrom., 2019, 444, 116172.
[http://dx.doi.org/10.1016/j.ijms.2019.06.008]
[38]
Weseloh, G.; Wolf, C.; König, W.A. A new application of capillary zone electrophoresis: Determination of energy barriers of configurationally labile chiral compounds. Angew. Chem. Int. Ed. Engl., 1995, 34(15), 1635-1636.
[http://dx.doi.org/10.1002/anie.199516351]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy